The closure of schools, libraries, gyms, and extracurricular activities due to the Covid-19 pandemic has parents and teachers concerned about the impact on children’s learning and development. But children are not the …
Read More »Alcoholism in the era of Kovid-19
In mid-March, as schools and businesses began to close and people started moving back home, 44-year-old yoga instructor in Portland, Maine, Amanda (who asked that her real name not be used for …
Read More »Lily’s Alzheimer’s News Risked Plant of Upside, Limited
Eli Lilly’s positive data on experimental Alzheimer’s disease treatment is expected news for patients and, now, a winner on Wall Street. Lilly shares gained 12% in trading on Monday morning, with the …
Read More »Los Angeles doctors identify coronovirus-related psychosis in the patient
LOS ANGELES (KABC) – The physical effects of COVID-19 are ongoing in congested hospitals in Southern California, but concern is growing over the mental effects of the virus. Research is uncovering cases …
Read More »depression? Can cause bacteria in your stomach – or it can make you healthier
Scientists are looking for evidence that orchestrated can be a major emotion for microorganisms living in and around our bodies, affecting our health and well-being. In a series of studies, researchers are …
Read More »Alzheimer’s research appears in hot spots in America
Where you live in case of Alzheimer’s disease risk. Scientists and medical researchers know that advanced age and certain changes in the brain increase the likelihood of developing Alzheimer’s disease and related …
Read More »About 1 to 5 in mental development after COVID-19
Editor’s note: Get the latest COVID-19 news and guidance at Medscape’s Coronavirus Resource Center. One in five COVID-19 patients are diagnosed with a psychiatric disorder such as anxiety or depression within 3 …
Read More »Indications point to FDA approval to treat Biogen’s experimental Alzheimer’s disease, although there are doubts
Odds are growing that Food and Drug Administration officials said Biogen Inc.’s experimental and somewhat controversial Alzheimer’s disease drug could be approved because there was enough evidence in clinical trials to prove …
Read More »Biogen stock leaps as a sign of FDA approval for its Alzheimer’s drug
Word size Aducanumab targets plaque produced in the brain cells of Alzheimer’s patients. Dream time BiogenOf Luck turned on Wednesday. Prior to Friday’s meeting at the company’s request for treatment for Alzheimer’s …
Read More »Kovid-19’s lasting impact on health care
Kovid-19 will certainly change many aspects of drug approval and the overall regulatory process for biomedical product innovation – first and foremost, collaboration in areas across borders and new and stronger emphasis …
Read More »